Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05387603 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors.

Study acronym: START-NET
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 10, 2025 (before its estimated October 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Oct 2025 to Oct 1, 2026v4
  2. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised at 4 of 4 sites
    v3
  3. Start date changed from estimate of Jun 2022 to Nov 1, 2022
    • Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Eligibility criteria expanded, about 45 words
    • Site contacts updated at 4 of 4 sites
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
There are several ways of personalizing PRRT (peptide receptor radionuclide treatment) in NEN (neuroendocrine neoplasia). Nevertheless, the current treatment regimen is not personalized. This trial aims to compare personalized PRRT to non-personalized PRRT in terms of safety, efficacy and resource demands in order to optimize treatment outcomes in an evidence-based manner in future.
Trial Details
NCT Number NCT05387603
Lead Sponsor Lund University Hospital
Conditions
(from sponsor)		 Neuroendocrine Tumors
Related terms Neuroendocrine Tumors
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov